Antidepressant medication and ocular factors in association with the need for anti-VEGF retreatment in neovascular age-related macular degeneration.

CONCLUSION: This study provides evidence that treatment with antidepressant medication increases the anti-VEGF retreatment requirement in patients with nAMD, possibly through the interplay of antidepressant medication, depression status and VEGF levels. PMID: 30030393 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30030393?dopt=Abstract

Source: The British Journal of Ophthalmology - July 20, 2018 Category: Opthalmology Authors: Mantel I, Zola M, Mir O, Gaillard R, Behar-Cohen F Tags: Br J Ophthalmol Source Type: research